Descrizione Clinica
Igiene intimate Xanacist 15cpr
XANACIST
Description
Medical device indicated both for the prevention of cystitis onset and as a coadjuvant in therapeutic treatment. The high content of PAC-A (proantocianidine-A), present in the extract of cranberry, in fact generates a barrier effect against the adhesion of bacteria to the epithelium of the bladder.
Ingredients
D-mannose, ursin grapes (Arctostaphylos grapes L.) dry extract leaves titulate to 20% in arbutin, cranberry (Vaccinium macrocarpum Aiton) dried extract titolato to 40% in proantocianidine, beta-glucano, cellulose, dicalcium phosphate, carbossimetilcellulose sodium reticulate, magnesium hydropropyl.
Without gluten.
Mode of use
1 tablet per day, taken orally with a glass of water, preferably in the evening for at least one month either in case of recurring infections or after a specific treatment, even with antibiotic therapy. In case of event in place it is recommended to take 2 tablets daily.
Warnings
Xanacist is a medical device well tolerated at the recommended dose. The medical device does not replace the antibiotic therapy needed to treat urinary infections. Do not exceed the recommended maximum daily dose. In case of pediatric patients or pregnant women, consult your doctor. In those patients who are in anticoagulant therapy (warfarin), it is recommended to consult the doctor or pharmacist before using the device. If symptoms persist, consult your doctor. Suspend intake in case of allergic reaction or intolerance. Keep away from the reach and sight of children. Always consume and only whole tablets, preserved properly. Dispose of expired tablets and packaging in accordance with the local provisions in force.
Conservation
Store in a cool, dry place, away from heat sources.
The expiry date refers to the correctly stored product in a package.
Validity of whole packaging: 36 months.
Format
Pack of 15 tablets.
Net weight: 11.3 g.
Medical device indicated both for the prevention of cystitis onset and as a coadjuvant in therapeutic treatment. The high content of PAC-A (proantocianidine-A), present in the extract of cranberry, in fact generates a barrier effect against the adhesion of bacteria to the epithelium of the bladder.
Ingredients
D-mannose, ursin grapes (Arctostaphylos grapes L.) dry extract leaves titulate to 20% in arbutin, cranberry (Vaccinium macrocarpum Aiton) dried extract titolato to 40% in proantocianidine, beta-glucano, cellulose, dicalcium phosphate, carbossimetilcellulose sodium reticulate, magnesium hydropropyl.
Without gluten.
Mode of use
1 tablet per day, taken orally with a glass of water, preferably in the evening for at least one month either in case of recurring infections or after a specific treatment, even with antibiotic therapy. In case of event in place it is recommended to take 2 tablets daily.
Warnings
Xanacist is a medical device well tolerated at the recommended dose. The medical device does not replace the antibiotic therapy needed to treat urinary infections. Do not exceed the recommended maximum daily dose. In case of pediatric patients or pregnant women, consult your doctor. In those patients who are in anticoagulant therapy (warfarin), it is recommended to consult the doctor or pharmacist before using the device. If symptoms persist, consult your doctor. Suspend intake in case of allergic reaction or intolerance. Keep away from the reach and sight of children. Always consume and only whole tablets, preserved properly. Dispose of expired tablets and packaging in accordance with the local provisions in force.
Conservation
Store in a cool, dry place, away from heat sources.
The expiry date refers to the correctly stored product in a package.
Validity of whole packaging: 36 months.
Format
Pack of 15 tablets.
Net weight: 11.3 g.
